I know this is old news but this is only 2 hours old.
Highly anticipated immuno-oncology drug, pembrolizumab, which has shown promising results in trials as a treatment for Melanoma could be approved by the US FDA. The drug is a product from Merck & Co’s, and is being hailed as a treatment for melanoma.
If the drug is approved it will become the first from a promising class of drug which have been designed to fend off cancer by blocking a protein Programmed Death receptor (PD-1), or a related target known as PD-L1, used by tumors to dodge disease-fighting cells.
It is also called Mk – 3475 and belongs to the same class as Bristol Myer Squibb’s Nivolumab. Both the drugs are undergoing clinical trials. The drug is going to be soon available in Japan (Nivolumab).
The drug is being manufactured by Bristol-Myers Squibb, Roche Holding AG and AstraZeneca Plc, who are racing to create similar treatments for different types of cancers. The new class of drugs is expected to be worth $30 billion in annual sales worldwide by 2025 and this is one of the reasons for big multinationals who are investing billions of dollars in research.
The US FDA is expected to take a decision by October 28 on the Merck’s application. However sources are hinting that approval for the new drug could happen within the coming weeks. The sources spoke on conditions of anonymity since they are not authorized to speak to the press. There is also a possibility that FDA delays the approval. A spokeswoman for the FDA said that they could not reveal the status of the applications.
Merck will be promoting the drug in treating melanoma which is not responding to conventional treatment which uses Yervoy, a Bristol-Myers immunotherapy that targets a different part of the immune system. Studies have also revealed that pembrolizumab contract tumors in about a third of patients with late-stage melanoma. More than 10,000 Americans succumb to melanoma each year.
Any Idea where that coal is coming from? That makes a difference in ton-miles. TIA.
I'd look it up myself but I don't know what article or reference you're using. You ARE using some credible source right?
"no need for anyone to post here who doesn't know anything about shipping..."
What are you? the posting police?
Premarket has heavy volume (for a premarket) and a high of 3.30
I guess JRMILLS is screwed being short. and lakers_fan as well. oh well. better them than me.
Have a great day !!
As Warren Buffet once said: "time to buy is when there is blood on the streets". You are not looking forward.
I'm on the east coast US. The corn here is almost as tall as the trees (ok I'm exaggerating just a little bit but the corn is VERY tall). Seriously: most all corn stalks have at least 2 ears on them and many have 3. I've seen quite a few with 4.
Well there aren't any on THIS board. so what board you talking about?
The immediate problem that is tanking the market is that the ukrainans and russian militarys are duking it out on ukranian soil. --- bottom line: Putin has invaded with an armored column.
Yes, the ONCS move was sweet. I sold that off at .78 (cents). But it is WAY too early to buy PSTI. Good luck if you throw in with Allo who has lied for the past several years.